June 12th 2025
The Resident Physician Shortage Reduction Act of 2025 would add 14,000 Medicare-support training slots over seven years and codify rural residency support.
Under new legislation, patients would get far fewer suggestions to ‘ask your doctor if…’
Vaccine panel gets eight new members with no vetting, questionable backgrounds, according to doctors and mothers.
Reimbursement based on Medicare Economics Index will have a cost but ensure beneficiary access, commission says.
Earlier this week, 17 sitting members were dismissed.
Trump announces CDC, FDA and surgeon general nominations
Dave Weldon, MD, Marty Makary, MD, MPH, FACS, and Janette Nesheiwat, MD, are the President-elect’s picks for CDC director, FDA commissioner and surgeon general.
CMS reports strong start to 2025 marketplace open enrollment, builds on record-setting success
Nearly 500,000 uninsured signed up for coverage in 2025
Study highlights alarming life expectancy gap in the U.S.
Researchers issue a call for action on health disparities among ethnic groups
5 objectives for achieving high-quality primary care at the state level
Key objectives for the improvement of primary care at the state level were discussed in an expert-led AHCJ webinar, titled "No one can see you now."
Primary care-centric ACOs generate better savings and better outcomes
PCC’s 2024 Evidence Report found primary care-centric ACOs generate more than two times higher savings through data integration.
Global medical costs to increase by double digits for third straight year, survey finds
Rising utilization and pharmacy costs, along with new technologies, blamed for the rise
Study finds patients paying for insurance still pile on medical debt, or skip care to avoid it
Commonwealth Fund examines underinsureds, now more than 20% of the people with health insurance around the country.
Dallas jury finds practice liable for Medicare fraud that could result in more than $300 million in penalties
Jury finds that more than 20,000 false claims were filed
Physician discipline in the new age of telehealth
New York’s licensure rules can complicate cross-state medical practice with potential widespread professional repercussions.
Medicaid ‘at an unprecedented crossroads … progress is at risk,’ program leader says
CMS Medicaid chief foreshadows potential policy changes coming when President-elect Trump moves into the White House.
USPSTF releases the 14th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services
The U.S. Preventive Services Task Force highlights key research gaps in their recommendations intended to promote public health for all.
CMS chief: ‘It is the greatest honor and privilege to serve in this role’
Brooks-LaSure describes achievements in her final national leadership call.
Most Medicare beneficiaries risk overspending on prescription plans
Study shows that most beneficiaries skip comparing Part D plans that might better suit their needs and their wallet
Consumers have faced the challenge of limited health insurance options for the past decade, says AMA report
A recent market analysis outlined the lack of adequate health insurer competition in many U.S. markets.
Health insurance is at risk if premium tax credits are eliminated – a slideshow
How many people will be affected if Congress does not extend premium tax credits for ACA insurance?
Trump names Dr. Oz to head CMS
Famed television host will join RFK Jr. ‘to take on the illness industrial complex,’ president-elect says in news reports.
Private equity and publicly traded hospices show lower caregiver satisfaction compared to not-for-profits
Study shows that ownership model matters when it comes to caregiver satisfaction, and that doctors should know the ownership structure of hospices.
Everything you missed from the Interim Meeting of the AMA House of Delegates
The AMA Interim Meeting of the House of Delegates was held November 8-12, in Orlando, Florida. Here is everything you might have missed.
Facing the student debt crisis: 3 strategies to establish control
From promises of widespread forgiveness to halted payments, followed by a chaotic mess of legal disputes over repayment plans, federal student loan borrowers are on an emotional rollercoaster.
Patient safety falling short: States where hospitals need improvement – a slideshow
Some states have few or no hospitals with ‘A’ grades for patient safety, according to the Leapfrog Group’s fall 2024 report card.
Ep 44: Noncompete clauses with Emma Schuering, JD
Emma Schuering, JD, of the Polsinelli law firm discusses non-compete agreements in health care.
Safeguarding innovation and access with nuclear medicine policy
As we prepare for a new Congress in January, it’s essential to ensure legislators and their staff fully understand the implications of nuclear medicine policy shifts on patient care and medical innovation.
Trump picks RFK Jr. for HHS Secretary
Trump taps vaccine skeptic Kennedy at HHS to 'make America healthy again.'
October inflation went up – but within expectations
CPI up 0.2% for the month, up to 2.6% overall
‘American health care is struggling’ – Assistant AG discusses morality, money and medicine
Antitrust chief says the nation is at an inflection point to restore competition or pay more money for less choice and more aggravation.
COVID-19 medical misinformation prompts much hand-wringing, but little hand-slapping for docs
Study finds spreading medical misinformation is low on the list of reasons for disciplinary actions against physicians in recent years.
AMA supports additional oversight for nonprofit hospital charity care
In a recent announcement, the AMA announced its support of more standardization and regulation of nonprofit hospitals.
AMA calls for regulatory and injunctive actions for unpaid preauthorized care
New policy would ensure AMA support for a federal prohibition on the inappropriate denial of payment for care that is necessary and has received prior authorization.
High labor costs hitting hospitals as physicians generate less revenue
Revenue is increasing but physicians and providers are working more while generating less money.
What Donald Trump's election means for pharma: Insight from the 2024 Global Pharma and Biotech Summit
A panel at the Financial Times’ 2024 Global Pharma and Biotech Summit in London analyzed what the re-election of Trump could mean to the pharmaceutical industry.